Conecte-se

Bibliografias temáticas / Psychopharmacology / Artigos de revistas

Siga este link para ver outros tipos de publicações sobre o tema: Psychopharmacology.

Artigos de revistas sobre o tema "Psychopharmacology"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 29 de julho de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Psychopharmacology".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Birnbaum, Robert J. "Neuroscience and Psychopharmacology into the Next Millennium". CNS Spectrums 4, n.º 7 (julho de 1999): 36–52. http://dx.doi.org/10.1017/s1092852900012001.

Texto completo da fonte

Resumo:

AbstractThe end of the millennium provides an opportunity to review some of the common practices that were present in psychopharmacology during the 20th century. The author focuses on two approaches that have dominated research and guided the clinical application of psychopharmacologic therapeutics: the unitary clinically-based and single-lesion perspectives. The author expands upon these older formulations of neuropsychiatric disease pathogenesis and describes how the approach to psychopharmacologic research and therapeutics has changed in light of advances in the basic neurosciences. Relevant recent advances in the basic neurosciences that shed light on the pathophysiology of neuropsychiatric disease states and that guide psychopharmacologic practices are described. The use of atypical antipsychotic agents to treat schizophrenia is given as one example of the clinical applications of the approach to psychopharmacology in the next century.

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Spies, M., e S. Kasper. "A European psychopharmacology curriculum: The young psychiatrist's point of view". European Psychiatry 33, S1 (março de 2016): S63. http://dx.doi.org/10.1016/j.eurpsy.2016.01.956.

Texto completo da fonte

Resumo:

It goes without saying that psychopharmacologic treatment requires extensive knowledge of topics ranging from pharmacodynamics and efficacy, to pharmacokinetics, side-effects, and toxicity. Knowledge should be supplemented with experience regarding applicability in a clinical setting. It is well accepted that comprehensive psychopharmacologic education is essential to convey necessary knowledge and adequately prepare trainees for independent practice [1]. Currently, a psychopharmacologic curriculum, under the umbrella of the European Psychiatric Association, is in preparation in order to emphasize the importance of psychopharmacologic education in the context of psychiatric training and to foster standardization within the European Union. The aim of this presentation is to discuss psychopharmacologic education and prerequisites for an effective curriculum from the trainee's point of view. We will address challenges facing psychiatric trainees [2] and review existing curricula as well as literature in which they are evaluated. Based on evaluation of the model curriculum by the American Society of Clinical Psychopharmacology, one of the most broadly used psychopharmacologic curricula, it has been emphasized that an effective curriculum should be more than a list of topics. It should also convey pedagogic strategies with a focus on up-to-date technology, and provide a process through which teacher and trainee progress can be assessed [3,4]. Reflection on currently available curricula should aid in the development of an effective and timely EU-wide psychopharmacologic curriculum.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Zisook, Sidney. "Psychopharmacology". Journal of Clinical Psychiatry 59, n.º 4 (15 de abril de 1998): 201. http://dx.doi.org/10.4088/jcp.v59n0410.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Rothschild, Anthony J. "Psychopharmacology". Journal of Clinical Psychopharmacology 42, n.º 1 (janeiro de 2022): 1–2. http://dx.doi.org/10.1097/jcp.0000000000001518.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Cameron, Oliver G. "Psychopharmacology". Psychosomatic Medicine 61, n.º 5 (setembro de 1999): 585–90. http://dx.doi.org/10.1097/00006842-199909000-00001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Potokar, John, e David Nutt. "Psychopharmacology". Current Opinion in Psychiatry 9, n.º 1 (janeiro de 1996): 98–104. http://dx.doi.org/10.1097/00001504-199601000-00020.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Scahill, Lawrence, Kathleen Koenig, Deirdre H. Carroll e Maryellen Pachler. "Psychopharmacology." Journal of Child and Adolescent Psychiatric Nursing 20, n.º 3 (agosto de 2007): 188–90. http://dx.doi.org/10.1111/j.1744-6171.2007.00112.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

SMITH, JEAN C., WILLIAM L. COLEMAN, CATHERINE L. GRUS e ADRIAN D. SANDLER. "PSYCHOPHARMACOLOGY". Journal of Developmental & Behavioral Pediatrics 17, n.º 1 (fevereiro de 1996): 66. http://dx.doi.org/10.1097/00004703-199602000-00023.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

M, Campbell, e Cueva JE. "PSYCHOPHARMACOLOGY". Journal of Developmental & Behavioral Pediatrics 17, n.º 2 (abril de 1996): 131. http://dx.doi.org/10.1097/00004703-199604000-00037.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

&NA;, &NA;. "PSYCHOPHARMACOLOGY". Journal of Developmental & Behavioral Pediatrics 17, n.º 5 (outubro de 1996): 368–69. http://dx.doi.org/10.1097/00004703-199610000-00027.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Conners, CK, CD Casat, CT Gualtieri, E. Weller, M. Reader e A. Reiss. "PSYCHOPHARMACOLOGY". Journal of Developmental & Behavioral Pediatrics 18, n.º 3 (junho de 1997): 212. http://dx.doi.org/10.1097/00004703-199706000-00031.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

&NA;, &NA;. "PSYCHOPHARMACOLOGY". Journal of Developmental & Behavioral Pediatrics 18, n.º 5 (outubro de 1997): 358. http://dx.doi.org/10.1097/00004703-199710000-00026.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

&NA;, &NA;. "PSYCHOPHARMACOLOGY". Journal of Developmental & Behavioral Pediatrics 18, n.º 6 (dezembro de 1997): 433. http://dx.doi.org/10.1097/00004703-199712000-00025.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

SANDLER, ADRIAN D. "Psychopharmacology". Journal of Developmental & Behavioral Pediatrics 23, n.º 5 (outubro de 2002): 393. http://dx.doi.org/10.1097/00004703-200210000-00029.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

REIFF, MICHAEL I. "Psychopharmacology". Journal of Developmental & Behavioral Pediatrics 23, n.º 5 (outubro de 2002): 393. http://dx.doi.org/10.1097/00004703-200210000-00030.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

SANDLER, ADRIAN D. "Psychopharmacology". Journal of Developmental & Behavioral Pediatrics 23, n.º 5 (outubro de 2002): 393–94. http://dx.doi.org/10.1097/00004703-200210000-00031.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Shulman, Stanford T. "Psychopharmacology". Pediatric Annals 36, n.º 9 (1 de setembro de 2007): 527–28. http://dx.doi.org/10.3928/0090-4481-20070901-01.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

&NA;. "Psychopharmacology". International Clinical Psychopharmacology 5, n.º 2 (abril de 1990): 161–62. http://dx.doi.org/10.1097/00004850-199004000-00014.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 1, n.º 1 (fevereiro de 1989): 75–78. http://dx.doi.org/10.1176/jnp.1.1.75.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 1, n.º 2 (maio de 1989): 210–12. http://dx.doi.org/10.1176/jnp.1.2.210.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 1, n.º 3 (agosto de 1989): 324–26. http://dx.doi.org/10.1176/jnp.1.3.324.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 1, n.º 4 (novembro de 1989): 435–37. http://dx.doi.org/10.1176/jnp.1.4.435.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 2, n.º 1 (fevereiro de 1990): 106–7. http://dx.doi.org/10.1176/jnp.2.1.106.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 2, n.º 2 (maio de 1990): 230–31. http://dx.doi.org/10.1176/jnp.2.2.230.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 2, n.º 3 (agosto de 1990): 342–43. http://dx.doi.org/10.1176/jnp.2.3.342.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 2, n.º 4 (novembro de 1990): 457–58. http://dx.doi.org/10.1176/jnp.2.4.457.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Thronson, L. Renata, e Genevieve L. Pagalilauan. "Psychopharmacology". Medical Clinics of North America 98, n.º 5 (setembro de 2014): 927–58. http://dx.doi.org/10.1016/j.mcna.2014.06.001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Minchin, M. C. W. "Psychopharmacology". Neuropharmacology 25, n.º 1 (janeiro de 1986): 109. http://dx.doi.org/10.1016/0028-3908(86)90066-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 3, n.º 1 (fevereiro de 1991): 108–10. http://dx.doi.org/10.1176/jnp.3.1.108.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 3, n.º 2 (maio de 1991): 223–24. http://dx.doi.org/10.1176/jnp.3.2.223.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 3, n.º 3 (agosto de 1991): 341–42. http://dx.doi.org/10.1176/jnp.3.3.341.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 3, n.º 4 (novembro de 1991): 447–48. http://dx.doi.org/10.1176/jnp.3.4.447.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 4, n.º 1 (fevereiro de 1992): 103–4. http://dx.doi.org/10.1176/jnp.4.1.103.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 4, n.º 2 (maio de 1992): 220–21. http://dx.doi.org/10.1176/jnp.4.2.220.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Silver, Jonathan M. "Psychopharmacology". Journal of Neuropsychiatry and Clinical Neurosciences 4, n.º 3 (agosto de 1992): 339–40. http://dx.doi.org/10.1176/jnp.4.3.339.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Hammersley, Diane. "Psychopharmacology". Counselling Psychology Review 35, n.º 1 (junho de 2020): 29–32. http://dx.doi.org/10.53841/bpscpr.2020.35.1.29.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Vance, Alasdair L. A. "Book Review: Child Psychopharmacology: Child Psychopharmacology". Australian & New Zealand Journal of Psychiatry 33, n.º 6 (dezembro de 1999): 965. http://dx.doi.org/10.1080/0004867990437.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Lantos, Vera. "Book Review: Psychopharmacology: Evidence-Based Psychopharmacology". Canadian Journal of Psychiatry 52, n.º 5 (maio de 2007): 333–34. http://dx.doi.org/10.1177/070674370705200509.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

REMINGTON, GARY. "Psychopharmacology of Antipsychotics Psychopharmacology of Antidepressants". American Journal of Psychiatry 158, n.º 9 (setembro de 2001): 1538. http://dx.doi.org/10.1176/appi.ajp.158.9.1538.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Glick, Ira D. "Improving Efficiency and Effectiveness of Psychopharmacology Practice: What Must Be Done and What Shouldn't Be Done". Psychiatric Annals 53, n.º 7 (julho de 2023): 294–97. http://dx.doi.org/10.3928/00485713-20230614-01.

Texto completo da fonte

Resumo:

As the science and the data underlying psychopharmacology treatments has become roughly equal to the science underlying medical illness, the level of quality care to achieve psychopharmacology clinical competence in practice has become more difficult for clinicians. This article aims to fill the gap in teaching psychopharmacology and raise the quality level by describing the core tasks for prescribing quality clinical psychopharmacology. We describe reasons why the quality is low, the most common clinical practices that are not being done, and most importantly, delineate the necessary elements for initial and ongoing follow-up visits. The goal is an integrated approach incorporating objective, subjective, and relational factors in psychopharmacology practice. [ Psychiatr Ann . 2023;53(7):294–297.]

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Jobson, K. "International Psychopharmacology Algorithm Project: Algorithms in Psychopharmacology". International Journal of Psychiatry in Clinical Practice 1, sup1 (janeiro de 1997): S3. http://dx.doi.org/10.3109/13651509709024748.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Stimmel, Glen L. "Book Review: Psychopharmacology: Part 1: Preclinical Psychopharmacology". Drug Intelligence & Clinical Pharmacy 19, n.º 2 (fevereiro de 1985): 153. http://dx.doi.org/10.1177/106002808501900217.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Calhoun, Laura. "Book Review: Psychopharmacology: Handbook of Female Psychopharmacology". Canadian Journal of Psychiatry 50, n.º 3 (março de 2005): 180–81. http://dx.doi.org/10.1177/070674370505000310.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Braslow, Joel T., e Stephen R. Marder. "History of Psychopharmacology". Annual Review of Clinical Psychology 15, n.º 1 (7 de maio de 2019): 25–50. http://dx.doi.org/10.1146/annurev-clinpsy-050718-095514.

Texto completo da fonte

Resumo:

We live in an age of psychopharmacology. One in six persons currently takes a psychotropic drug. These drugs have profoundly shaped our scientific and cultural understanding of psychiatric disease. By way of a historical review, we try to make sense of psychiatry's dependency on psychiatric drugs in the care of patients. Modern psychopharmacology began in 1950 with the synthesis of chlorpromazine. Over the course of the next 50 years, the psychiatric understanding and treatment of mental illness radically changed. Psychotropic drugs played a major part in these changes as state hospitals closed and psychotherapy gave way to drug prescriptions. Our review suggests that the success of psychopharmacology was not the consequence of increasingly more effective drugs for discrete psychiatric diseases. Instead, a complex mix of political economic realities, pharmaceutical marketing, basic science advances, and changes in the mental health-care system have led to our current infatuation with psychopharmacology.

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Ebert, Michael H. "Essential Psychopharmacology". Journal of Clinical Psychiatry 59, n.º 5 (15 de maio de 1998): 258. http://dx.doi.org/10.4088/jcp.v59n0510a.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Kwentus, Joseph A. "Geriatric Psychopharmacology". Journal of Clinical Psychiatry 59, n.º 11 (15 de novembro de 1998): 625–26. http://dx.doi.org/10.4088/jcp.v59n1110b.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Swann, Alan C. "Adaptive Psychopharmacology". Psychiatric Annals 35, n.º 10 (1 de outubro de 2005): 831–38. http://dx.doi.org/10.3928/00485713-20051001-08.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

McLean, Alvin, Diana D. Cardenas, Jodie K. Haselkorn e Michael Peters. "Cognitive Psychopharmacology". NeuroRehabilitation 3, n.º 2 (15 de junho de 1993): 1–14. http://dx.doi.org/10.3233/nre-1993-3203.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Gaumer, Carol Blakely. "Psychopharmacology Handbook". Journal of Psychosocial Nursing and Mental Health Services 34, n.º 9 (setembro de 1996): 53. http://dx.doi.org/10.3928/0279-3695-19960901-24.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Nazeer, Ahsan. "Pediatric Psychopharmacology". Psychiatric Annals 51, n.º 10 (outubro de 2021): 447–48. http://dx.doi.org/10.3928/00485713-20210910-01.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!